Taysha Gene Therapies
TSHA
TSHA
48 hedge funds and large institutions have $362M invested in Taysha Gene Therapies in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
7% less capital invested
Capital invested by funds: $388M → $362M (-$26.2M)
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$15.2M | |
| 2 | +$3.85M | |
| 3 | +$3.3M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.85M |
| 5 |
Morgan Stanley
New York
|
+$1.66M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$6.79M | |
| 3 | -$4.55M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$717K |
| 5 |
Millennium Management
New York
|
-$639K |